Key Segments
By Treatment Type
- Pharmacological Treatments
- Laxatives
- NSAIDs
- Corticosteroids
- Local Anesthetics
- Herbals
- Others (e.g., flavonoids, vasoconstrictors, astringents)
- Non-Surgical Procedures
- Rubber Band Ligation
- Sclerotherapy
- Infrared Coagulation
- Cryotherapy
- Surgical Procedures
- Hemorrhoidectomy
- Stapled Hemorrhoidopexy
By Route of Administration
- Oral
- Topical
- Rectal
By Type
- Internal Hemorrhoids
- External Hemorrhoids
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Aging populations are more prone to constipation and chronic venous insufficiency, leading to increased hemorrhoid incidence and thus driving higher demand for both medical and surgical treatments.
Ans: Topical treatments, suppositories, and non-surgical procedures like rubber band ligation are widely used due to convenience and efficacy in early-stage hemorrhoids.
Ans: Key players include Abbott, Sanofi, Bayer, Church & Dwight, GlaxoSmithKline, Boston Scientific, and Sebela Pharmaceuticals, offering both drug-based and device-assisted treatments.
Ans: Minimally invasive procedures like infrared coagulation, laser therapy, and radiofrequency ablation are gaining traction due to shorter recovery times and reduced postoperative complications.
Ans: North America holds the largest market share due to high healthcare expenditure and awareness, while the Asia-Pacific region is the fastest-growing due to improving access to healthcare and an increasing patient pool.